Amprenavir (Agenerase)
Overview
- A Clinical Overview of Amprenavir (Agenerase) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health - Prescribing Information for Amprenavir (Agenerase) Capsules (PDF) (May 2005)
From GlaxoSmithKline - Prescribing Information for Amprenavir (Agenerase) Oral Solution (PDF) (May 2005)
From GlaxoSmithKline - Drug Interactions: Amprenavir (August 2004)
From Project Inform
News
- Agenerase (Amprenavir) Oral Solution and 50-mg Capsules to Be Discontinued in the U.S. (October 2007)
To read PDF, click here
From GlaxoSmithKline
Research
- Literature Citations for Amprenavir (Regularly Updated)
From U.S. National Institutes of Health - Clinical Trials Using Amprenavir (Regularly Updated)
U.S. and international trials currently recruiting.
From U.S. National Institutes of Health - Dosing Agenerase + Kaletra -- Trying to Juggle, Walk and Chew Gum All at the Same Time (March/April 2004)
A study presented at CROI 2004 bolsters support for the use of therapeutic drug monitoring to customize dosing.
In Positively Aware, from Test Positive Aware Network - Using Genotypic Inhibitory Quotient to Measure Response to Boosted-Amprenavir Regimen (July 15, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
Clinical Management
Clinical Management
  |